AzTrials
AzTrials

Smoking CessationNCT07021417

Effectiveness of Primary Care Nurse-supervised Educational Group Interventions for Giving up Smoking

A study testing Workshop and Course in people with Smoking Cessation, run by Universidad de Murcia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: To analyze the effectiveness of two group interventions for smoking cessa-tion (with support from the app) conducted by primary care nurses. Methods: A multi-center randomized controlled clinical trial occurred across eight Health Centres in the Murcia Region from 2018 to 2019. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Smoking Cessation
What is being tested?
Workshop and Course
Could I receive a placebo?
No, everyone receives an active treatment
How many people
83 participants
Where
1 siteSpain
Study dates
1 May 2018to 1 Feb 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Daily smokers aged over 18 years.
  • Smoking history of at least one year.
  • Intention to quit smoking within one month.
  • Ability to communicate in Spanish.
  • Ownership of a mobile device with internet access.

Who cannot join

  • Consumption of other drugs (excluding cannabis).
  • Participation in smoking cessation programmes within the past year.
  • Diagnosis of an acute psychotic disorder.
  • Adolescents.
  • Pregnant women.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Faculty of Nursing

    Cartagena, Murcia, 30203

Other trials in Spain

About this study

Official title: Effectiveness of Primary Care Nurse-supervised Educational Group Interventions for Giving up Smoking: A Randomized Con-trolled Trial

Background: To analyze the effectiveness of two group interventions for smoking cessa-tion (with support from the app) conducted by primary care nurses. Methods: A multi-center randomized controlled clinical trial occurred across eight Health Centres in the Murcia Region from 2018 to 2019. It involved daily smokers aged 18 and older who wanted to quit, had internet access, and spoke Spanish. Pregnant women, polydrug users, and individuals with psychiatric disorders were excluded from participation. Participants were randomly divided into two groups: one attending a single 4-hour Workshop, and the other attending a Course consisting of four 2-hour sessions. The analysis of smoking abstinence was performed using SPSS V22, with intragroup differences assessed through the chi-square test.

Read the detailed description

The project was conceived as a randomised, multicentre clinical trial aimed at comparing the efficacy of two group-based intervention modalities for smoking cessation, both led by primary care nurses and supplemented by using the S'Acabó mobile application. The study was conducted in health centres across the Region of Murcia between 2018 and 2019, with participants being followed up for one year. The target population comprised adult smokers who expressed a desire to quit smoking, had internet access, and did not present with severe psychiatric disorders or concurrent substance use.

Allocation to the intervention groups was performed randomly: one group participated in a single four-hour workshop, whilst the other attended a course consisting of four weekly sessions, each lasting two hours. Both modalities incorporated cognitive-behavioural techniques and participatory methodologies to enhance individual motivation and group learning through the exchange of experiences and peer support.

The nurses responsible for delivering the interventions received specific training in smoking cessation, group education, and the management of group dynamics, thereby ensuring the standardisation and quality of the process. The study protocol included the systematic collection of sociodemographic, clinical, and tobacco consumption data, the assessment of psychological variables and the utilisation of complementary resources, including the mobile application. Follow-up of participants was conducted through face-to-face visits and telephone contacts at various points throughout the year, enabling the monitoring of the smoking cessation process and adherence to the proposed strategies. Statistical analysis of the data was carried out by international methodological standards, employing validated tools and ensuring the robustness and reliability of the results obtained.

Being tested
Workshop, Course
Keywords
Nurses, Nursing Evaluation Research, Primary Health Care, Smoking Cessation
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WorkshopBehavioural

    includes a single 4-hour session

  • CourseBehavioural

    Includes four weekly sessions totaling 8 hours (2 hours each)

Study groups in NCT07021417
Study groupRoleWhat they receive
WorkshopExperimentalFormat: A single group session of four hours' duration. Structure: All content and activities were concentrated into a single meeting. Methodology: Cognitive-behavioural techniques and participatory dynamics were employed, fostering motivation and vicarious learning among group members. Focus: The initial parts of the session were oriented towards preparing participants for smoking cessation, whilst the final segment focused on maintaining abstinence and preventing relapse. Materials: A standardised presentation and a procedural guide were utilised to ensure the homogeneity of the intervention. Digital Support: All participants received instructions on how to use the S'Acabó mobile application as a complement to the workshop.
Receives: Behavioral: Workshop
CourseExperimentalFormat: A group programme comprising four weekly sessions of two hours each (eight hours in total). Structure: Sessions were distributed over the course of one month, allowing for a more gradual and sustained accompaniment. Methodology: Cognitive-behavioural techniques and participatory strategies were applied, facilitating the exchange of experiences and mutual support among participants. Focus: The first two sessions focused on preparation for smoking cessation, while the third and fourth sessions were dedicated to maintaining abstinence and preventing relapse. Materials: The same standardised materials and procedural guides as those used in the single workshop were employed. Digital Support: Use of the S'Acabó mobile application was also recommended as reinforcement for the content addressed in the face-to-face sessions.
Receives: Behavioral: Course

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants who are abstinent (self-reported abstinence corroborated by an exhaled carbon-monoxide reading, expressed in parts per million).

    Assessment of effectiveness: Abstinence rates for the Course and the Workshop groups will be compared by means of the χ² test at 3-, 6-, 9- and 12-month follow-ups. Data will be analysed with SPSS v22; statistical significance will be set at p < 0.05.

    Measured: Up to 12 months post-intervention (telephone contacts at months 3 and 9; face-to-face visits with carbon-monoxide testing at months 6 and 12).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2025
  2. Study start1 May 2018
  3. Primary completion1 Dec 2019
  4. Study completion1 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
83 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07021417
Sponsor's protocol ID
06052025
Other IDs
FFIS17/CE/01/26
Status last verified
May 2025
First submitted
8 May 2025
Last updated
15 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Workshop and Course in people with Smoking Cessation, run by Universidad de Murcia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants who are abstinent (self-reported abstinence corroborated by an exhaled carbon-monoxide reading, expressed in parts per million). (time frame: Up to 12 months post-intervention (telephone contacts at months 3 and 9; face-to-face visits with carbon-monoxide testing at months 6 and 12).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in